The Strathclyde Institute of Pharmacy & Biomedical Sciences is a major research centre in Scotland and is amongst the UK's top Schools of Pharmacy. We have a wide range of state-of-the-art research facilities and recently benefited from the opening of a new £36m building.
Cellular Basis of Disease
Research Group Lead: Professor Luke Chamberlain
The Cellular Basis of Disease research group investigates molecular and cellular processes that link to a range of important disorders. The group employ a wide array of cutting-edge techniques, working at the molecular, cellular and systems level and using a range of disease models. Research themes of the group focus on cardiovascular and metabolic disease, neurological disorders and mental health, cancer and inflammation.
The group has a weekly seminar programme that features both external speakers, and students and post-doctoral scientists affiliated to the group. The group encourage enquiries from prospective research fellows and PhD students. The research profile of group members can be viewed via the links below.
Through the discovery, development and manufacture of innovative drugs millions of people’s lives are saved and the quality of life for many others are improved. The Pharmaceutical Sciences research at the Strathclyde Institute of Pharmacy and Biomedical Sciences contributes to this by uniting internationally-leading researchers in the development, manufacture and testing of the next generation of medicines that promote the effective delivery and targeting of drugs.
The Strathclyde Institute of Pharmacy & Biomedical Sciences
John Arbuthnott Building (Hamnett Wing)
161 Cathedral Street
+44 (0)141 548 2125